Pfizer to raise U.S. drug prices in January after previously backing down
The logo of U.S. pharmaceutical corporation Pfizer Inc. at a branch in Zurich, Switzerland October 2, 2018. REUTERS/Arnd Wiegmann/File Photo/ NEW YORK (Reuters) - Pfizer Inc said on Friday that it plans to hike U.S. prices on 41 of its medicines in January, after walking back its previous planned price increases this summer under pressure from President Donald Trump. The largest U.S. drugmaker said in a statement that the increases would be on around 10 percent of its medicines. Pfizer said it would raise the list price of most of the drugs ...
Click
To Read Full Article